Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
Centro de investigación
Hospital de Móstoles
Móstoles, EspañaPublicacións en colaboración con investigadores/as de Hospital de Móstoles (22)
2024
-
Validation of the CoVID-TE model as a tool to predict thrombosis, bleeding, and mortality in the oncology patient with Sars-Cov-2 infection: a study by the SEOM cancer and thrombosis group
Clinical and Translational Oncology, Vol. 26, Núm. 1, pp. 171-177
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Germline mutations in WNK2 could be associated with serrated polyposis syndrome
Journal of Medical Genetics, Vol. 60, Núm. 6, pp. 557-567
2022
-
Adherence to endoscopic surveillance for advanced lesions and colorectal cancer in inflammatory bowel disease: an AEG and GETECCU collaborative cohort study
Alimentary pharmacology & therapeutics, Vol. 55, Núm. 11, pp. 1402-1413
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
-
Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome
Clinical Gastroenterology and Hepatology, Vol. 20, Núm. 3, pp. 611-621.e9
2021
-
Body mass index and disease activity in chronic inflammatory rheumatic diseases: Results of the cardiovascular in rheumatology (CARMA) project
Journal of Clinical Medicine, Vol. 10, Núm. 3, pp. 1-10
-
Rate of non-invasive follicular thyroid neoplasms with papillary-like nuclear features depends on pathologist’s criteria: a multicentre retrospective Southern European study with prolonged follow-up
Endocrine, Vol. 73, Núm. 1, pp. 131-140
-
Safety in the use of ultrasound in rheumatology during the COVID-19 Pandemic. Spanish Society of Rheumatology positioning paper
Reumatologia Clinica, Vol. 17, Núm. 5, pp. 284-289
2020
-
Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicing
International Journal of Cancer, Vol. 146, Núm. 2, pp. 521-530
2017
-
Evolution after Anti-TNF Discontinuation in Patients with Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study
American Journal of Gastroenterology, Vol. 112, Núm. 1, pp. 120-131
-
Reduced schedules of 4CMenB vaccine in infants and catch-up series in children: Immunogenicity and safety results from a randomised open-label phase 3b trial
Vaccine, Vol. 35, Núm. 28, pp. 3548-3557
2015
-
Erratum to "Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project" [Semin Arthritis Rheum 44 (2015) 618-626]
Seminars in Arthritis and Rheumatism
-
Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain
Seminars in Arthritis and Rheumatism, Vol. 44, Núm. 6, pp. 633-640
2014
2011
-
Enseñanza de ecografía en la reumatología española: 15 años de experiencia
Reumatologia Clinica, Vol. 7, Núm. 6, pp. 354-356
2010
-
Efectividad de palivizumab en la prevención de la infección por el virus respiratorio sincitial en prematuros de 321 a 35° semanas de gestación en España
Acta Pediatrica Espanola, Vol. 68, Núm. 1, pp. 13-18
2008
-
Etiología de la infección urinaria baja adquirida en la comunidad y resistencia de Escherichia coli a los antimicrobianos de primera línea. Estudio nacional multicéntrico
Medicina Clinica, Vol. 130, Núm. 13, pp. 481-486
2006
-
Desarrollo y validación de un cuestionario de satisfacción con el tratamiento en pacientes con artritis reumatoide
Reumatologia Clinica, Vol. 2, Núm. 3, pp. 137-145
2005
-
Large B-cell lymphoma with Hodgkin's features
Histopathology, Vol. 47, Núm. 1, pp. 101-110